Keri K

Strategic Investor | Focused on Medical Innovation, Emerging Technologies & Energy

📍 United States🔄 Updated October 2026💼 1 investments📅 10 years investing🗓 Last invested Nov 2016
Angel investor🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Nov 2016
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
early stageBiotechnology
Experience · 2 entries
All (2)
Investments (1)
2016
Private Investor
Nov 2016
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
early stageBiotechnology
2012
Associate Scientist
Jun 2012
We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines